Financials Catheter Precision, Inc.
Equities
VTAK
US74933X3026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 USD | -0.60% | -4.87% | +23.67% |
Valuation
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 2.841 | 3.787 | - | - |
Enterprise Value (EV) 1 | 2.841 | 3.787 | 3.787 | 3.787 |
P/E ratio | -0.03 x | -0.57 x | -1.32 x | -7.14 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | 1.19 x | 0.43 x | 0.22 x |
EV / Revenue | - | 1.19 x | 0.43 x | 0.22 x |
EV / EBITDA | - | - | - | - |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 7,027 | 7,573 | - | - |
Reference price 2 | 0.4043 | 0.5000 | 0.5000 | 0.5000 |
Announcement Date | 4/1/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net sales 1 | - | 3.19 | 8.85 | 17.26 |
EBITDA | - | - | - | - |
EBIT 1 | - | -7.79 | -5.44 | -1.26 |
Operating Margin | - | -244.2% | -61.47% | -7.3% |
Earnings before Tax (EBT) 1 | - | -7.79 | -5.44 | -1.26 |
Net income 1 | -70.57 | -7.79 | -5.44 | -1.26 |
Net margin | - | -244.2% | -61.47% | -7.3% |
EPS 2 | -12.99 | -0.8700 | -0.3800 | -0.0700 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 4/1/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|
Net sales 1 | 5 | 0.082 | 0.29 | 1.06 | 1.66 | 1.46 | 1.61 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -2.616 | -2.1 | -1.8 | -1.39 | -2.04 | -1.55 |
Operating Margin | - | -3,190.24% | -724.14% | -169.81% | -83.73% | -139.73% | -96.27% |
Earnings before Tax (EBT) 1 | - | -2.675 | -2.1 | -1.8 | -1.39 | -2.04 | -1.55 |
Net income 1 | - | -2.675 | -2.1 | -1.8 | -1.39 | -2.04 | -1.55 |
Net margin | - | -3,262.2% | -724.14% | -169.81% | -83.73% | -139.73% | -96.27% |
EPS 2 | - | -0.3600 | -0.2600 | -0.1800 | -0.1200 | -0.1600 | -0.1100 |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | - | 5/6/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net Debt | - | - | - | - |
Net Cash position | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets 1 | - | - | - | - |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex 1 | - | 0.4 | 0.5 | - |
Capex / Sales | - | 12.54% | 5.65% | - |
Announcement Date | 4/1/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.67% | 3.79M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- VTAK Stock
- Financials Catheter Precision, Inc.